These outcomes, along with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 help the strategy of focusing on ACKR3 as a novel solution to modulate the opioid system, which could open up new therapeutic avenues for opioid-related Diseases. The location is protected. https://juvenalk381ytk6.get-blogging.com/profile